IXICO plc (LON:IXI – Get Free Report)’s stock price passed above its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of GBX 11.39 ($0.14) and traded as high as GBX 12 ($0.15). IXICO shares last traded at GBX 12 ($0.15), with a volume of 10,000 shares trading hands.
IXICO Price Performance
The company has a market capitalization of £6.04 million, a price-to-earnings ratio of -312.50, a P/E/G ratio of -0.38 and a beta of 0.86. The business has a 50 day moving average price of GBX 11.51 and a 200-day moving average price of GBX 9.56. The company has a debt-to-equity ratio of 3.22, a quick ratio of 4.90 and a current ratio of 3.64.
Insider Activity at IXICO
In related news, insider Grant Nash acquired 260,000 shares of the firm’s stock in a transaction on Wednesday, December 4th. The stock was purchased at an average cost of GBX 12 ($0.15) per share, with a total value of £31,200 ($37,960.82). 30.28% of the stock is currently owned by corporate insiders.
About IXICO
IXICO is a fast growing and profitable medical data analytics company, providing data management and advanced analytics to the pharmaceutical clinical trials market. Established in 2004 and listed as a public company in October 2013, IXICO has firmly established itself as a trusted partner to the global pharmaceutical industry developing new therapies for neurological conditions such as Alzheimer’s, Parkinson’s and Huntington’s disease.
Our purpose is to advance medicine and human health by turning data into clinically meaningful information, providing valuable new insights in neuroscience.
Recommended Stories
- Five stocks we like better than IXICO
- Learn Technical Analysis Skills to Master the Stock Market
- AI Demand Sparks Opportunities for These 3 Nuclear Energy Leaders
- The Role Economic Reports Play in a Successful Investment Strategy
- TSMC: Long-Term Outlook Still Strong as Geopolitical Risk Rises
- Expert Stock Trading Psychology Tips
- Uber’s NVIDIA Deal and Buybacks Signal Major Upside
Receive News & Ratings for IXICO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IXICO and related companies with MarketBeat.com's FREE daily email newsletter.